Warning: The NCBI web site requires JavaScript to function. more...
Unbalanced chromosome 1 abnormalities leading to partial trisomy 1q in four infants with Down syndrome and acute megakaryocytic leukemia.
Silva ML, do Socorro Pombo-de-Oliveira M, Raimondi SC, Mkrtchyan H, Abdelhay E, de Figueiredo AF, de Souza MT, Garcia DR, de Ventura EM, de Sousa AM, Liehr T.
Mol Cytogenet. 2009 Feb 19;2:7.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.
Rainis L, Bercovich D, Strehl S, Teigler-Schlegel A, Stark B, Trka J, Amariglio N, Biondi A, Muler I, Rechavi G, Kempski H, Haas OA, Izraeli S.
Blood. 2003 Aug 1;102(3):981-6. Epub 2003 Mar 20.
Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology.
Xavier AC, Ge Y, Taub JW.
J Mol Diagn. 2009 Sep;11(5):371-80. Review.
Molecular lesions in childhood and adult acute megakaryoblastic leukaemia.
Hama A, Muramatsu H, Makishima H, Sugimoto Y, Szpurka H, Jasek M, O'Keefe C, Takahashi Y, Sakaguchi H, Doisaki S, Shimada A, Watanabe N, Kato K, Kiyoi H, Naoe T, Kojima S, Maciejewski JP.
Br J Haematol. 2012 Feb;156(3):316-325. doi: 10.1111/j.1365-2141.2011.08948.x. Epub 2011 Nov 28.
Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
Cushing T, Clericuzio CL, Wilson CS, Taub JW, Ge Y, Reichard KK, Winter SS.
J Pediatr. 2006 May;148(5):687-9.
miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.
Klusmann JH, Li Z, Böhmer K, Maroz A, Koch ML, Emmrich S, Godinho FJ, Orkin SH, Reinhardt D.
Genes Dev. 2010 Mar 1;24(5):478-90.
High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL, Dastugue N, Macintyre E, Denis C, Bauters F, Kerckaert JP, Cosson A, Fenaux P.
Blood. 2000 Oct 15;96(8):2862-9.
Acute monocytic leukemia and multiple abnormalities in a child with duplication of 1q detected by GTG-banding and SKY.
Scrideli CA, Baruffi MR, Squire JA, Ramos ES, Karaskova J, Heck B, Tone LG.
Leuk Res. 2005 Dec;29(12):1465-7. Epub 2005 Jun 16.
GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.
Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A.
Blood. 2003 Jun 1;101(11):4301-4. Epub 2003 Feb 13.
Myeloid leukemia in down syndrome.
Khan I, Malinge S, Crispino J.
Crit Rev Oncog. 2011;16(1-2):25-36.
Down syndrome, drug metabolism and chromosome 21.
Taub JW, Ge Y.
Pediatr Blood Cancer. 2005 Jan;44(1):33-9. Review.
Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling.
Bourquin JP, Subramanian A, Langebrake C, Reinhardt D, Bernard O, Ballerini P, Baruchel A, Cavé H, Dastugue N, Hasle H, Kaspers GL, Lessard M, Michaux L, Vyas P, van Wering E, Zwaan CM, Golub TR, Orkin SH.
Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3339-44. Epub 2006 Feb 21.
Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.
Xu G, Nagano M, Kanezaki R, Toki T, Hayashi Y, Taketani T, Taki T, Mitui T, Koike K, Kato K, Imaizumi M, Sekine I, Ikeda Y, Hanada R, Sako M, Kudo K, Kojima S, Ohneda O, Yamamoto M, Ito E.
Blood. 2003 Oct 15;102(8):2960-8. Epub 2003 Jun 19.
Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD.
Blood Cells Mol Dis. 2003 Nov-Dec;31(3):351-6.
Complex karyotype defined by molecular cytogenetic FISH and M-FISH in an infant with acute megakaryoblastic leukemia and neurofibromatosis.
Marques-Salles Tde J, Mkrtchyan H, Leite EP, Soares-Ventura EM, Muniz MT, Silva EF, Liehr T, Silva ML, Santos N.
Cancer Genet Cytogenet. 2010 Jul 15;200(2):167-9.
Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C, Creutzig U, Reinhardt D.
Klin Padiatr. 2005 May-Jun;217(3):126-34.
Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
Kobayashi K, Usami I, Kubota M, Nishio T, Kakazu N.
Cancer Genet Cytogenet. 2005 Apr 15;158(2):184-7. Review.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.
Ge Y, LaFiura KM, Dombkowski AA, Chen Q, Payton SG, Buck SA, Salagrama S, Diakiw AE, Matherly LH, Taub JW.
Leukemia. 2008 Mar;22(3):521-9. Epub 2007 Dec 20.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on